Researchers at the College of Veterinary Medicine plan to develop an enzyme-based technology into a range of diagnostic tests that can be performed anywhere using a handheld device.
North American white-tailed deer – shown in 2021 surveys of five states to have SARS-CoV-2 infection rates of up to 40% – shed and transmit the virus for up to five days once infected, according to a new study.
Students in the Weill Cornell Medical College Class of 2022 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.
Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease, according to a new study from researchers at Weill Cornell Medicine.
Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert Einstein College of Medicine.
Meiogenix, a next-generation technology startup that helps agricultural crops find their own genetic solutions, via chromosome editing, has joined Cornell’s McGovern Center incubator.
Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study.
